Novartis AG's growth products as percent of pharma revenue 2009-2016

Published by
Matej Mikulic,
May 22, 2024
This statistic depicts the contribution of growth products to the pharmaceutical revenue of multinational pharmaceutical company Novartis from 2009 to 2016. Novartis AG is one of the largest pharmaceutical companies and is based in Basel, Switzerland. In 2009, Novartis generated a pharmaceutical revenue of some 28.3 billion U.S. dollars. Some 14 percent of this amount were generated by growth products.

Contribution of Novartis AG's growth products to pharmaceutical revenue from 2009 to 2016*

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2017

Region

Worldwide

Survey time period

2009 to 2016

Supplementary notes

* Novartis Pharmaceuticals division. Growth products are defined as products launched since 2009 or later, or with exclusivity until at least the next four years in key markets (EU, US, Japan).
** With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
This statistic was assembled from several editions of the Novartis annual report.

Open this statistic in...
French
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market worldwide

Overview

5

Segments

7

Companies

8

R&D, patents, new products

8

Outlook

7

Focus: COVID-19 response

6

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

NovartisGlobal pharmaceutical industryPharmaceutical industry in the U.S.Pfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu